Laboratorios Farmaceuticos Rovi SA
Closed
SectorHealthcare
58.7 -0.42
Overview
Share price change
24h
Min
58.65
Max
59.25
Income | 80M 89M |
|---|---|
Sales | 39M 192M |
P/E Sector Avg | 16.312 68.51 |
EPS | 1.466 |
Dividend yield | 1.64 |
Profit margin | 46.582 |
Employees | 2,470 |
EBITDA | 83M 101M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +25.7% upside |
Dividend yield Sector Avg | 1.64% 2.29% |
|---|---|
Next Earnings | 5 lis 2026 |
Market Cap | 245M 3B |
|---|---|
Previous open | 59.12 |
Previous close | 58.7 |
News Sentiment
By Acuity
50%
50%
175 / 340 Ranking in Healthcare
Laboratorios Farmaceuticos Rovi SA Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Laboratorios Farmaceuticos Rovi SA Forecast
Price Target
By TipRanks
12 Months Forecast
Average 73.6 EUR 25.7%
High 83 EUR
Low 64.2 EUR
Based on 2 Wall Street analysts offering 12 month price targets forLaboratorios Farmaceuticos Rovi SA - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$